Form 4 for HALO HALOZYME THERAPEUTICS, INC.
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-16 · accession 0001159036-26-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-16 | HALO | Torley Helen | Pres AND CEO, Dir | F - Tax | $79.44 | -48.0K | 726.2K | -6% | -$3.82M |
| DM | 2026-02-17 | 2026-02-16 | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +89.1K | 735.3K | +14% | $0 |
| DM | 2026-02-17 | 2026-02-16 | HALO | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | -89.1K | 16.9K | -84% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | F | D | 11,334 | $79.44 | 718,394 | D | — | — | (F1) The reported disposition of 11,334 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 2 | Common | Common Stock | 2026-02-16 | F | D | 27,605 | $79.44 | 749,731 | D | — | — | (F3) The reported disposition of 27,605 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 3 | Common | Common Stock | 2026-02-16 | F | D | 9,104 | $79.44 | 726,165 | D | — | — | (F2) The reported disposition of 9,104 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations. |
| 4 | Common | Common Stock | 2026-02-16 | M | A | 51,171 | $0.00 | 777,336 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-16 | M | A | 21,009 | $0.00 | 729,728 | D | — | — | |
| 6 | Common | Common Stock | 2026-02-16 | M | A | 16,875 | $0.00 | 735,269 | D | — | — | |
| 7 | Derivative | Restricted Stock Units | 2026-02-16 | M | D | 21,009 | $0.00 | 0 | D | $0.00 · — to — | 21,009 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |
| 8 | Derivative | Performance Stock Units | 2026-02-16 | M | D | 51,171 | $0.00 | 0 | D | $0.00 · — to — | 51,171 Common Stock | (F5) This transaction represents the vesting and settlement of performance stock units in shares of common stock of the issuer. |
| 9 | Derivative | Restricted Stock Units | 2026-02-16 | M | D | 16,875 | $0.00 | 16,874 | D | $0.00 · — to — | 16,875 Common Stock | (F4) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer. |